2015
DOI: 10.1016/j.annemergmed.2015.03.016
|View full text |Cite
|
Sign up to set email alerts
|

The Safety and Effectiveness of Droperidol for Sedation of Acute Behavioral Disturbance in the Emergency Department

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

7
69
3

Year Published

2015
2015
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 80 publications
(79 citation statements)
references
References 19 publications
7
69
3
Order By: Relevance
“…Furthermore, the publication of state health policies from both NSW and Queensland in 2015 may also have contributed to the observed changes in the prescribing pattern. In the present study, droperidol 10 mg was the most commonly prescribed dose, which is consistent with the dose used in several clinical studies . Although emerging data from observational studies show that ketamine appears to be effective in managing severely agitated patients, it was not commonly used in the participating EDs in this study.…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…Furthermore, the publication of state health policies from both NSW and Queensland in 2015 may also have contributed to the observed changes in the prescribing pattern. In the present study, droperidol 10 mg was the most commonly prescribed dose, which is consistent with the dose used in several clinical studies . Although emerging data from observational studies show that ketamine appears to be effective in managing severely agitated patients, it was not commonly used in the participating EDs in this study.…”
Section: Discussionsupporting
confidence: 83%
“…In a survey conducted in 2009, midazolam was reported as the most preferred choice of parenteral sedation for agitation management among Australasian College of Emergency Medicine members, and it is the first‐line therapy recommended in the Therapeutic Guidelines for behavioural emergencies . The increasing number of studies documenting the efficacy and safety of droperidol in the Australian ED setting in the past 5 years may have reduced markedly the preference for midazolam. Furthermore, the publication of state health policies from both NSW and Queensland in 2015 may also have contributed to the observed changes in the prescribing pattern.…”
Section: Discussionmentioning
confidence: 99%
“…This guideline was based on studies that demonstrated droperidol to be a safe and affective choice of sedation agent. As such it was recommended as the first‐ and second‐line agent to be used for this group of patients . In our study, droperidol was used 86% ( n = 149) of the time, indicating that clinicians are familiar with this drug and are compliant with the NSW guideline.…”
Section: Discussionmentioning
confidence: 74%
“…In line with previous work conducted in the studied department and other departments, droperidol was the first‐line agent in all of these patients (Calver et al . , ).…”
Section: Discussionmentioning
confidence: 99%